7 Ways AI/ML Tools Are Revolutionizing Biotech

As the premier cloud suite for improving productivity in computational science research, Nuvolos is perfectly set up to enable modern-day AI/ML workflows in biotech. On previous occasions, we have outlined how Nuvolos makes using tools like RFDiffusion and AlphaFold 2 easier and faster, as well as how Nuvolos integrates seamlessly with essential AI notebook tools like JupyterAI.

But that's only scratching the surface. As practitioners in the field of biotech know well, AI/ML methods and technologies are revolutionizing how research in the life sciences is performed, and Nuvolos is there to support this process every step of the way. 

These technologies have opened up new possibilities for researchers, enabling them to analyze vast amounts of data, discover novel insights, and accelerate drug development. In this blog post, we will explore 7 different types of AI and ML tools commonly used in biotech research, highlighting their significance and applications.

All of these can be deployed on Nuvolos, allowing you to save substantial time and costs on your research workflow without having to change your favorite working environment or tools at all. Combined with the unlimited scalability offered by cloud compute resources, these 7 areas provide a handy illustration of how Nuvolos supports the cutting edge in biotech research and will continue to do so into the future.

One of the fundamental aspects of biotech research is dealing with massive datasets, ranging from genomics to proteomics. AI/ML tools play a critical role in processing, organizing, and visualizing this data.

Data visualization tools help researchers present complex biological information in an accessible manner, facilitating data-driven decision making. Obvious examples here are standard visualization tools like Matplotlib and Seaborn, but one can also think of more specialized applications like nglview, a Jupyter widget to interactively view molecular structures and trajectories.

AI/ML have transformed drug discovery and design, making the process faster and more efficient. Researchers use predictive models to identify potential drug candidates and predict their efficacy with remarkable accuracy. By analyzing molecular structures and interactions, AI-driven algorithms can prioritize compounds for further testing, reducing the time and resources required for drug development.

In this domain, one can think of tools like REINVENT 4, an AI tool for de novo drug design (among other uses), RDKit, an open source tool for cheminformatics and machine learning, and DeepChem, an open source toolchain for AI/ML in drug discovery, materials science, quantum chemistry, and biology.

Both early diagnosis and prediction of diseases are crucial for improving patient outcomes. AI/ML algorithms are used to analyze patient data, such as medical records and diagnostic images, in order to identify patterns and risk factors associated with various diseases. These tools can aid in the early detection of common conditions like cancer, diabetes, and neurodegenerative disorders, enabling timely intervention and personalized treatment plans.

Good examples include CheXNet, a convolutional neural network (CNN) that improves on human specialist performance in using AI/ML to diagnose pneumonia on sets of chest X-rays, and PathAI, which uses AI/ML to enhance pathology by assisting fast diagnoses from histopathology slides.

The concept of personalized medicine revolves around tailoring medical treatment to the individual characteristics of each patient. AI/ML is instrumental in permitting fast and efficient ways to analyze a patient's genetic makeup, medical history, and lifestyle to create personalized treatment plans. This not only enhances the effectiveness of therapies but also minimizes adverse effects, enabling a cutting-edge patient-centric approach to healthcare that may well be the future of medicine.

While naturally there are many proprietary, closed in-house solutions in this field, there are also open source tools that are useful to researchers in general. Examples are OpenCRAVAT, an advanced open source tool for annotating and prioritizing genomic variants, and GENCODE, a large general access project for annotating all gene features in humans and mice.

Finding new uses for existing drugs is a cost-effective strategy in drug development. AI/ML can accelerate this process by helping analyze vast datasets of drug interactions and biological pathways. By identifying potential targets and repurposing existing medications, researchers can bring new therapeutic options to market faster and at a lower cost. AI/ML tools suitable for these purposes include CLUE, which integrates toolsets for machine learning on CMap and LINCS datasets, in turn derived from machine learning on databases of gene expression. Other examples of such databases include the Drug Repurposing Hub.

Biomarkers are critical indicators of disease presence and progression. AI/ML tools are employed to sift through extensive biological data and identify relevant biomarkers associated with specific conditions. These biomarkers can then be used for early diagnosis, disease monitoring, and drug development (as mentioned above), contributing to advancements in precision medicine. An example is XGBoost, a library that implements machine learning algorithms in an efficient way for gradient boosting.

Understanding the three-dimensional structures of proteins is vital for drug design and disease treatment. AI/ML techniques have made significant strides in predicting protein structures accurately. This breakthrough has the potential to revolutionize drug discovery by allowing researchers to design drugs that specifically target proteins involved in disease pathways. We already mentioned AlphaFold 2 and RFDiffusion as core examples, but there are many implementations in proteomics building further on these advances, like AF2Complex, used to predict protein-protein interactions, and DMPFold2 for fast protein structure prediction.

In short, AI/ML is already revolutionizing biotech and broader life sciences research in many different domains. As a result, researchers in these fields are expected to be familiar with machine learning-driven tools and workflows. By offering an integrated cloud suite for computational research tools, Nuvolos improves productivity, collaboration, and ease-of-use in any AI/ML tooling in the life sciences, and provides access to the unlimited resources of cloud computing (including GPUs). It comes with a practical UI for easy project management and scaling, but does not require researchers to change anything about their familiar working environment, tooling, or workflow - it works directly in the browser.

Interested in trying Nuvolos? Talk to us to get a free demonstration or trial period.